Morepen Laboratories Limited -1.48 % Drug Manufacturers - Major

Trend Analysis


Support and Resistance Levels Analysis
The current close value 16.7 is between the support and resistance channel of 15 and 17. The stock has a Sell Signal , 15 becomes a critical support to stop the fall and 17 is a immediate resistance on the upside.

Technical Indicators (3 Month duration)
Exponential Moving average 17.0
MACD value -0.3
Price range 16.55 to 21.70
Volume range 239277 to 2787832
Support & Resistance 15, 17
Stock Performance
Six Months -16.3%
Five Months-4.6%
Four Months-3.5%
Three Months-2.3%
Two Months-17.8%
One Month-2.3%
Last Six Months


Last Five Months


Last Four Months


Last Three Months


Last Two Months


Last One Month


Today's Price Range
3 Month Price Range
About Morepen Laboratories Limited
Morepen Laboratories Limited is an India-based pharmaceutical company. The Company operates through four segments; they are Active Pharmaceutical Ingredients (API), Domestic Formulations, Diagnostics and Over the Counter (OTC). The API segment has developed new products like Sitagliptin Phosphate, Rosuvastatin Calcium, Olmesartan Medoxomil and Aliskiren in the Research and Development laboratory. The Domestic Formulations segment markets over 100 branded formulations in 8 major therapeutic segments. The Diagnostics segment markets under its own brand name Clinical and Home Health devices and Blood Banking machines. The OTC segment market brands like Burnol ,Lemolate, Sat-Isabgol, Option -72, Head-X, Fever-X , C- Candy and other Over the Counter (OTC) products. The Company has 3 manufacturing facilities, for manufacture of API, formulations and OTC products with international standings.
See stocks similar to Morepen Laboratories Limited in Drug Manufacturers - Major

Morepen Laboratories Limited has Sell Signal. What is your opinion on it?

{ }